FDA Inspection 1224921 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Dec 7, 2023 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 7, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Louisville, KY (United States)